Bridgeway Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,300
| Closed | -$223K | – | 1211 |
|
|
2025
Q1 | $223K | Sell |
37,300
-31,772
| -46% | -$190K | 0.01% | 903 |
|
|
2024
Q4 | $530K | Buy |
69,072
+3,305
| +5% | +$25.4K | 0.01% | 801 |
|
|
2024
Q3 | $671K | Buy |
65,767
+3,350
| +5% | +$34.2K | 0.01% | 784 |
|
|
2024
Q2 | $926K | Buy |
62,417
+4,500
| +8% | +$66.8K | 0.02% | 711 |
|
|
2024
Q1 | $790K | Sell |
57,917
-63,313
| -52% | -$864K | 0.02% | 807 |
|
|
2023
Q4 | $1.33M | Sell |
121,230
-55,580
| -31% | -$609K | 0.03% | 696 |
|
|
2023
Q3 | $1.94M | Buy |
176,810
+9,006
| +5% | +$98.6K | 0.05% | 554 |
|
|
2023
Q2 | $2.22M | Sell |
167,804
-99,141
| -37% | -$1.31M | 0.05% | 511 |
|
|
2023
Q1 | $3.63M | Buy |
266,945
+23,445
| +10% | +$319K | 0.1% | 351 |
|
|
2022
Q4 | $4.76M | Hold |
243,500
| – | – | 0.12% | 286 |
|
|
2022
Q3 | $4.64M | Buy |
243,500
+128,500
| +112% | +$2.45M | 0.12% | 295 |
|
|
2022
Q2 | $2.37M | Buy |
+115,000
| New | +$2.37M | 0.05% | 487 |
|